The DOI matches its Crossref record; 227 of the 227 references it cites were found in a registry or an index.
Glutamate system, amyloid β peptides and tau protein: functional interrelationships and relevance to Alzheimer disease pathology
Open accessAbstract
Alzheimer disease is the most prevalent form of dementia globally and is characterized premortem by a gradual memory loss and deterioration of higher cognitive functions and postmortem by neuritic plaques containing amyloid β peptide and neurofibrillary tangles containing phospho-tau protein. Glutamate is the most abundant neurotransmitter in the brain and is essential to memory formation through processes such as long-term potentiation and so might be pivotal to Alzheimer disease progression. This review discusses how the glutamatergic system is impaired in Alzheimer disease and how interactions of amyloid β and glutamate influence synaptic function, tau phosphorylation and neurodegeneration. Interestingly, glutamate not only influences amyloid β production, but also amyloid β can alter the levels of glutamate at the synapse, indicating that small changes in the concentrations of both molecules could influence Alzheimer disease progression. Finally, we describe how the glutamate receptor antagonist, memantine, has been used in the treatment of individuals with Alzheimer disease and discuss its effectiveness.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alzheimer's Disease: Genes, Proteins, and Therapy
Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063
Global prevalence of dementia: a Delphi consensus study
Ferri, C. P., Prince, M., Brayne, C., Brodaty, H., Fratiglioni, L., Ganguli, M., Hall, K., Hasegawa, K., Hendrie, H., Huang, Y., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67889-0 · Cited by 5,332
Triple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles
Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126
Shankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., et al. (2008) · Nature Medicine · doi:10.1038/nm1782 · Cited by 3,685
Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., Pahwa, J. S., Moskvina, V., Dowzell, K., Williams, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.440 · Cited by 3,326
Pathways towards and Away from Alzheimer’s Disease
Mattson, M. P. (2004) · Nature · doi:10.1038/nature02621 · Cited by 3,052
Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease
the European Alzheimer's Disease Initiative Investigators, Lambert, J.-C., Heath, S., Even, G., Campion, D., Sleegers, K., Hiltunen, M., Combarros, O., Zelenika, D., Bullido, M. J., et al. (2009) · Nature Genetics · doi:10.1038/ng.439 · Cited by 2,234
Memantine in Moderate-to-Severe Alzheimer's Disease
Reisberg, B., Doody, R., Stöffler, A., Schmitt, F., Ferris, S., & Möbius, H. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa013128 · Cited by 2,043
RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
Yan, S. D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Zhao, L., Nagashima, M., Morser, J., et al. (1996) · Nature · doi:10.1038/382685a0 · Cited by 2,012
Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models
Ittner, L. M., Ke, Y. D., Delerue, F., Bi, M., Gladbach, A., van Eersel, J., Wölfing, H., Chieng, B. C., Christie, M. J., Napier, I. A., et al. (2010) · Cell · doi:10.1016/j.cell.2010.06.036 · Cited by 1,821
Alzheimer's Disease and the Amyloid-β Peptide
Murphy, M. P., & LeVine, H. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1221 · Cited by 1,750
APP Processing and Synaptic Function
Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T., Sisodia, S., & Malinow, R. (2003) · Neuron · doi:10.1016/s0896-6273(03)00124-7 · Cited by 1,644
Mattson, M., Cheng, B., Davis, D., Bryant, K., Lieberburg, I., & Rydel, R. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-02-00376.1992 · Cited by 1,627
Shankar, G. M., Bloodgood, B. L., Townsend, M., Walsh, D. M., Selkoe, D. J., & Sabatini, B. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4970-06.2007 · Cited by 1,592
Regulation of NMDA receptor trafficking by amyloid-β
Snyder, E. M., Nong, Y., Almeida, C. G., Paul, S., Moran, T., Choi, E. Y., Nairn, A. C., Salter, M. W., Lombroso, P. J., Gouras, G. K., et al. (2005) · Nature Neuroscience · doi:10.1038/nn1503 · Cited by 1,561
Hayashi, Y., Shi, S.-H., Esteban, J. A., Piccini, A., Poncer, J.-C., & Malinow, R. (2000) · Science · doi:10.1126/science.287.5461.2262 · Cited by 1,524
Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state
Pike, C., Burdick, D., Walencewicz, A., Glabe, C., & Cotman, C. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-04-01676.1993 · Cited by 1,417
Dong, X.-X., Wang, Y., & Qin, Z.-H. (2009) · Acta Pharmacologica Sinica · doi:10.1038/aps.2009.24 · Cited by 1,297
Correlation Between Elevated Levels of Amyloid β-Peptide in the Brain and Cognitive Decline
Näslund, J. (2000) · JAMA · doi:10.1001/jama.283.12.1571 · Cited by 1,268
The Expression of Vesicular Glutamate Transporters Defines Two Classes of Excitatory Synapse
Fremeau, R. T., Troyer, M. D., Pahner, I., Nygaard, G. O., Tran, C. H., Reimer, R. J., Bellocchio, E. E., Fortin, D., Storm-Mathisen, J., & Edwards, R. H. (2001) · Neuron · doi:10.1016/s0896-6273(01)00344-0 · Cited by 1,265
Synaptic Activity Regulates Interstitial Fluid Amyloid-β Levels In Vivo
Cirrito, J. R., Yamada, K. A., Finn, M. B., Sloviter, R. S., Bales, K. R., May, P. C., Schoepp, D. D., Paul, S. M., Mennerick, S., & Holtzman, D. M. (2005) · Neuron · doi:10.1016/j.neuron.2005.10.028 · Cited by 1,265
Cloning and expression of a rat brain L-glutamate transporter
Pines, G., Danbolt, N. C., Bjørås, M., Zhang, Y., Bendahan, A., Eide, L., Koepsell, H., Storm-Mathisen, J., Seeberg, E., & Kanner, B. I. (1992) · Nature · doi:10.1038/360464a0 · Cited by 1,232
Genome-wide Analysis of Genetic Loci Associated With Alzheimer Disease
Seshadri, S. (2010) · JAMA · doi:10.1001/jama.2010.574 · Cited by 1,219
Astrocyte glutamate transport: Review of properties, regulation, and physiological functions
Anderson, C. M., & Swanson, R. A. (2000) · Glia · doi:10.1002/1098-1136(200010)32:1<1::aid-glia10>3.0.co;2-w · Cited by 1,216
Guskiewicz, K. M., Marshall, S. W., Bailes, J., McCrea, M., Cantu, R. C., Randolph, C., & Jordan, B. D. (2005) · Neurosurgery · doi:10.1227/01.neu.0000175725.75780.dd · Cited by 1,197
Guskiewicz, K. M., Marshall, S. W., Bailes, J. E., McCrea, M., Cantu, R. C., RANDOLPH, C. C., & Jordan, B. D. (2005) · Neurosurgery · doi:10.1093/neurosurgery/57.4.719 · Cited by 1,196
Storck, T., Schulte, S., Hofmann, K., & Stoffel, W. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.10955 · Cited by 1,183
The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease
Rogaeva, E., Meng, Y., Lee, J. H., Gu, Y., Kawarai, T., Zou, F., Katayama, T., Baldwin, C. T., Cheng, R., Hasegawa, H., et al. (2007) · Nature Genetics · doi:10.1038/ng1943 · Cited by 1,167
Glutamate receptors in the mammalian central nervous system
Ozawa, S., Kamiya, H., & Tsuzuki, K. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(97)00085-3 · Cited by 1,122
AMPAR Removal Underlies Aβ-Induced Synaptic Depression and Dendritic Spine Loss
Hsieh, H., Boehm, J., Sato, C., Iwatsubo, T., Tomita, T., Sisodia, S., & Malinow, R. (2006) · Neuron · doi:10.1016/j.neuron.2006.10.035 · Cited by 1,042
Soluble oligomers of the amyloid β-protein impair synaptic plasticity and behavior
Selkoe, D. J. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.02.016 · Cited by 1,038
Li, S., Hong, S., Shepardson, N. E., Walsh, D. M., Shankar, G. M., & Selkoe, D. (2009) · Neuron · doi:10.1016/j.neuron.2009.05.012 · Cited by 972
Mechanisms of Neuronal Degeneration in Alzheimer's Disease
Yankner, B. A. (1996) · Neuron · doi:10.1016/s0896-6273(00)80115-4 · Cited by 955
Synaptic Targeting by Alzheimer's-Related Amyloid β Oligomers
Lacor, P. N., Buniel, M. C., Chang, L., Fernandez, S. J., Gong, Y., Viola, K. L., Lambert, M. P., Velasco, P. T., Bigio, E. H., Finch, C. E., et al. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3432-04.2004 · Cited by 954
Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer?s disease
HYND, M. (2004) · Neurochemistry International · doi:10.1016/j.neuint.2004.03.007 · Cited by 938
Caspase cleavage of tau: Linking amyloid and neurofibrillary tangles in Alzheimer's disease
Gamblin, T. C., Chen, F., Zambrano, A., Abraha, A., Lagalwar, S., Guillozet, A. L., Lu, M., Fu, Y., Garcia-Sierra, F., LaPointe, N., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1630428100 · Cited by 831
Alzheimer's Disease: Molecular Understanding Predicts Amyloid-Based Therapeutics
Selkoe, D. J., & Schenk, D. (2003) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.43.100901.140248 · Cited by 818
Tau is essential to β-amyloid-induced neurotoxicity
Rapoport, M., Dawson, H. N., Binder, L. I., Vitek, M. P., & Ferreira, A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092136199 · Cited by 807
Ionotropic and metabotropic glutamate receptor structure and pharmacology
Kew, J. N. C., & Kemp, J. A. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2200-z · Cited by 788
Liu, F., Grundke‐Iqbal, I., Iqbal, K., & Gong, C. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04391.x · Cited by 759
Scavenger receptor-mediated adhesion of microglia to β-amyloid fibrils
Khoury, J. E., Hickman, S. E., Thomas, C. A., Cao, L., Silverstein, S. C., & Loike, J. D. (1996) · Nature · doi:10.1038/382716a0 · Cited by 727
An overview of APP processing enzymes and products.
Chow, V. W., Mattson, M. P., Wong, P. C., & Gleichmann, M. (2010) · NeuroMolecular Medicine · doi:10.1007/s12017-009-8104-z · Cited by 684
Li, S., Jin, M., Koeglsperger, T., Shepardson, N. E., Shankar, G. M., & Selkoe, D. J. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.0203-11.2011 · Cited by 671
Metabotropic glutamate receptors
Ferraguti, F., & Shigemoto, R. (2006) · Cell and Tissue Research · doi:10.1007/s00441-006-0266-5 · Cited by 640
Endocytosis Is Required for Synaptic Activity-Dependent Release of Amyloid-β In Vivo
Cirrito, J. R., Kang, J.-E., Lee, J., Stewart, F. R., Verges, D. K., Silverio, L. M., Bu, G., Mennerick, S., & Holtzman, D. M. (2008) · Neuron · doi:10.1016/j.neuron.2008.02.003 · Cited by 635
β-Amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage
Koh, J.-Y., Yang, L. L., & Cotman, C. W. (1990) · Brain Research · doi:10.1016/0006-8993(90)91355-k · Cited by 617
Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration
Wang, J., Grundke‐Iqbal, I., & Iqbal, K. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.05226.x · Cited by 553
Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology
Rissman, R. A., Poon, W. W., Blurton-Jones, M., Oddo, S., Torp, R., Vitek, M. P., LaFerla, F. M., Rohn, T. T., & Cotman, C. W. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420640 · Cited by 543
Synapse Formation and Function Is Modulated by the Amyloid Precursor Protein
Priller, C., Bauer, T., Mitteregger, G., Krebs, B., Kretzschmar, H. A., & Herms, J. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1450-06.2006 · Cited by 542
Guo, Q., Fu, W., Sopher, B. L., Miller, M. W., Ware, C. B., Martin, G. M., & Mattson, M. P. (1999) · Nature Medicine · doi:10.1038/4789 · Cited by 489
Evolution of neuronal changes in the course of Alzheimer’s disease
Braak, H., & Braak, E. (1998) · Journal of Neural Transmission. Supplementa · doi:10.1007/978-3-7091-6467-9_11 · Cited by 483
Deficient glutamate tranport is associated with neurodegeneration in Alzheimer's disease
Masliah, E., Hansen, L., Alford, M., Deteresa, R., & Mallory, M. (1996) · Annals of Neurology · doi:10.1002/ana.410400512 · Cited by 476
PSD-95 is required for activity-driven synapse stabilization.
Ehrlich, I., Klein, M., Rumpel, S., & Malinow, R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609307104 · Cited by 470
Lauderback, C. M., Hackett, J. M., Huang, F. F., Keller, J. N., Szweda, L. I., Markesbery, W. R., & Butterfield, D. A. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00451.x · Cited by 464
Tau phosphorylation: physiological and pathological consequences
Stoothoff, W. H., & Johnson, G. V. W. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.06.017 · Cited by 442
ADAMs family members as amyloid precursor protein α‐secretases
Allinson, T. M. J., Parkin, E. T., Turner, A. J., & Hooper, N. M. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10737 · Cited by 440
Phosphatase Activity Toward Abnormally Phosphorylated τ: Decrease in Alzheimer Disease Brain
Gong, C., Shaikh, S., Wang, J., Zaidi, T., Grundke‐Iqbal, I., & Iqbal, K. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65020732.x · Cited by 438
Wang, H., Lee, D. H. S., Davis, C. B., & Shank, R. P. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0751155.x · Cited by 435
Phosphorylation of Tau by Fyn: Implications for Alzheimer's Disease
Lee, G., Thangavel, R., Sharma, V. M., Litersky, J. M., Bhaskar, K., Fang, S. M., Do, L. H., Andreadis, A., Van Hoesen, G., & Ksiezak-Reding, H. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4162-03.2004 · Cited by 414
Structural Correlates of Cognition in Dementia: Quantification and Assessment of Synapse Change
DeKosky, S. T., Scheff, S. W., & Styren, S. D. (1996) · Neurodegeneration · doi:10.1006/neur.1996.0056 · Cited by 405
Gong, C.-X., Lidsky, T., Wegiel, J., Zuck, L., Grundke-Iqbal, I., & Iqbal, K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.8.5535 · Cited by 405
Calpain-Mediated Signaling Mechanisms in Neuronal Injury and Neurodegeneration
Vosler, P. S., Brennan, C. S., & Chen, J. (2008) · Molecular Neurobiology · doi:10.1007/s12035-008-8036-x · Cited by 382
Alberdi, E., Sánchez-Gómez, M. V., Cavaliere, F., Pérez-Samartín, A., Zugaza, J. L., Trullas, R., Domercq, M., & Matute, C. (2010) · Cell Calcium · doi:10.1016/j.ceca.2009.12.010 · Cited by 364
Interactions between β-amyloid and central cholinergic neurons: implications for Alzheimer’s disease
Kar, S., Slowikowski, S. P. M., Westaway, D., & Mount, H. T. J. (2004) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0442 · Cited by 364
Self-citationAmyloid beta from axons and dendrites reduces local spine number and plasticity
Wei, W., Nguyen, L. N., Kessels, H. W., Hagiwara, H., Sisodia, S., & Malinow, R. (2010) · Nature Neuroscience · doi:10.1038/nn.2476 · Cited by 357
LI, S., MALLORY, M., ALFORD, M., TANAKA, S., & MASLIAH, E. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199708000-00008 · Cited by 343
Long-term synaptic plasticity in hippocampal interneurons
Kullmann, D. M., & Lamsa, K. P. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2207 · Cited by 340
The dysregulation of intracellular calcium in Alzheimer disease
Supnet, C., & Bezprozvanny, I. (2010) · Cell Calcium · doi:10.1016/j.ceca.2009.12.014 · Cited by 323
Klyubin, I., Betts, V., Welzel, A. T., Blennow, K., Zetterberg, H., Wallin, A., Lemere, C. A., Cullen, W. K., Peng, Y., Wisniewski, T., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.5161-07.2008 · Cited by 321
Zheng, W.-H., Bastianetto, S., Mennicken, F., Ma, W., & Kar, S. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00404-9 · Cited by 321
Self-citationJacob, C. P., Koutsilieri, E., Bartl, J., Neuen-Jacob, E., Arzberger, T., Zander, N., Ravid, R., Roggendorf, W., Riederer, P., & Grünblatt, E. (2007) · Journal of Alzheimer's Disease · doi:10.3233/jad-2007-11113 · Cited by 317
NMDA-mediated activation of the tyrosine phosphatase STEP regulates the duration of ERK signaling
Paul, S., Nairn, A. C., Wang, P., & Lombroso, P. J. (2003) · Nature Neuroscience · doi:10.1038/nn989 · Cited by 314
Dementia of Alzheimer’s disease and other neurodegenerative disorders—memantine, a new hope
Sonkusare, S. K., Kaul, C. L., & Ramarao, P. (2005) · Pharmacological Research · doi:10.1016/j.phrs.2004.05.005 · Cited by 307
Ferrer, I., Gomez-Isla, T., Puig, B., Freixes, M., Ribe, E., Dalfo, E., & Avila, J. (2005) · Current Alzheimer Research · doi:10.2174/1567205052772713 · Cited by 304
Chen, J.-H., Lin, K.-P., & Chen, Y.-C. (2009) · Journal of the Formosan Medical Association · doi:10.1016/s0929-6646(09)60402-2 · Cited by 288
The genetic architecture of Alzheimer's disease: beyond APP, PSENs and APOE
Guerreiro, R. J., Gustafson, D. R., & Hardy, J. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.03.025 · Cited by 285
PP2A mRNA Expression Is Quantitatively Decreased in Alzheimer's Disease Hippocampus
Vogelsberg-Ragaglia, V., Schuck, T., Trojanowski, J. Q., & Lee, V. M.-Y. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7630 · Cited by 281
Endogenous amyloid‐β is necessary for hippocampal synaptic plasticity and memory
Puzzo, D., Privitera, L., Fa', M., Staniszewski, A., Hashimoto, G., Aziz, F., Sakurai, M., Ribe, E. M., Troy, C. M., Mercken, M., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22313 · Cited by 278
Lack of Evidence for the Efficacy of Memantine in Mild Alzheimer Disease
Schneider, L. S. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.69 · Cited by 275
Harkany, T., Ábrahám, I., Timmerman, W., Laskay, G., Tóth, B., Sasvári, M., Kónya, C., Sebens, J. B., Korf, J., Nyakas, C., et al. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00164.x · Cited by 273
The Glutamatergic System and Alzheimer???s Disease: Therapeutic Implications
Butterfield, D. A., & Pocernich, C. B. (2003) · CNS Drugs · doi:10.2165/00023210-200317090-00004 · Cited by 267
The Production of Amyloid β Peptide Is a Critical Requirement for the Viability of Central Neurons
Plant, L. D., Boyle, J. P., Smith, I. F., Peers, C., & Pearson, H. A. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-13-05531.2003 · Cited by 266
Neuroprotection by memantine against neurodegeneration induced by β-amyloid(1–40)
Miguel-Hidalgo, J. J., Alvarez, X. A., Cacabelos, R., & Quack, G. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03731-9 · Cited by 265
Park, S.-Y., & Ferreira, A. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1125-05.2005 · Cited by 262
Pathologically activated therapeutics for neuroprotection
Lipton, S. A. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2229 · Cited by 257
Synaptic Changes in Alzheimer's Disease
Gylys, K. H., Fein, J. A., Yang, F., Wiley, D. J., Miller, C. A., & Cole, G. M. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63436-0 · Cited by 253
Memantine in Moderate to Severe Alzheimer’s Disease: a Meta-Analysis of Randomised Clinical Trials
Winblad, B., Jones, R. W., Wirth, Y., Stöffler, A., & Möbius, H. J. (2007) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000102568 · Cited by 253
Floden, A. M., Li, S., & Combs, C. K. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4998-04.2005 · Cited by 246
NMDA receptor mediates tau-induced neurotoxicity by calpain and ERK/MAPK activation
Amadoro, G., Ciotti, M. T., Costanzi, M., Cestari, V., Calissano, P., & Canu, N. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511065103 · Cited by 243
Glutamatergic systems in Alzheimer's disease
Francis, P. T. (2003) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.934 · Cited by 242
Lesort, M., Jope, R. S., & Johnson, G. V. W. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0720576.x · Cited by 240
Block of LTP in rat hippocampus in vivo by β-amyloid precursor protein fragments
Cullen, W. K., Suh, Y.-H., Anwyl, R., & Rowan, M. J. (1997) · NeuroReport · doi:10.1097/00001756-199710200-00006 · Cited by 235
Long-term potentiation and memory
Morris, R. G. M. (2003) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.2002.1230 · Cited by 232
Harris, M. E., Wang, Y., Pedigo, N. W., Hensley, K., Butterfield, D. A., & Carney, J. M. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67010277.x · Cited by 230
Sontag, E., Luangpirom, A., Hladik, C., Mudrak, I., Ogris, E., Speciale, S., & White, C. L. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.4.287 · Cited by 228
Immunotherapy for Alzheimer’s disease: Key Symposium: Immunotherapy for Alzheimer’s disease
Morgan, D. (2011) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02315.x · Cited by 225
Kurup, P., Zhang, Y., Xu, J., Venkitaramani, D. V., Haroutunian, V., Greengard, P., Nairn, A. C., & Lombroso, P. J. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.0157-10.2010 · Cited by 224
Matos, M., Augusto, E., Oliveira, C. R., & Agostinho, P. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.08.022 · Cited by 223
Kornhuber, J., & Weller, M. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(96)00047-9 · Cited by 222
Regulation of Amyloid Precursor Protein Cleavage
Mills, J., & Reiner, P. B. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0720443.x · Cited by 221
Memantine Improves Cognition and Reduces Alzheimer’s-Like Neuropathology in Transgenic Mice
Martinez-Coria, H., Green, K. N., Billings, L. M., Kitazawa, M., Albrecht, M., Rammes, G., Parsons, C. G., Gupta, S., Banerjee, P., & LaFerla, F. M. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090452 · Cited by 216
Molecular biology and genetics of Alzheimer's disease
St George-Hyslop, P. H., & Petit, A. (2005) · Comptes Rendus. Biologies · doi:10.1016/j.crvi.2004.10.013 · Cited by 210
Glutamate transporter variants reduce glutamate uptake in Alzheimer's disease
Scott, H. A., Gebhardt, F. M., Mitrovic, A. D., Vandenberg, R. J., & Dodd, P. R. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.03.008 · Cited by 202
The Role of Caspase Cleavage of Tau in Alzheimer Disease Neuropathology
Cotman, C. W., Poon, W. W., Rissman, R. A., & Blurton-Jones, M. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.2.104 · Cited by 199
NMDA Receptor Activation Inhibits α-Secretase and Promotes Neuronal Amyloid-β Production
Lesné, S., Ali, C., Gabriel, C., Croci, N., MacKenzie, E. T., Glabe, C. G., Plotkine, M., Marchand-Verrecchia, C., Vivien, D., & Buisson, A. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0849-05.2005 · Cited by 199
Glutamate transmission and toxicity in alzheimer's disease
Greenamyre, J. T., Maragos, W. F., Albin, R. L., Penney, J. B., & Young, A. B. (1988) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(88)90102-9 · Cited by 197
Bordji, K., Becerril-Ortega, J., Nicole, O., & Buisson, A. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3021-10.2010 · Cited by 197
Pathways by Which Aβ Facilitates Tau Pathology
Blurton-Jones, M., & LaFerla, F. (2006) · Current Alzheimer Research · doi:10.2174/156720506779025242 · Cited by 195
Zhang, Y., Venkitaramani, D. V., Gladding, C. M., Zhang, Y., Kurup, P., Molnar, E., Collingridge, G. L., & Lombroso, P. J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2666-08.2008 · Cited by 191
A three-step model for the synaptic recruitment of AMPA receptors
Opazo, P., & Choquet, D. (2011) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2010.08.014 · Cited by 190
Zhao, W.-Q., Santini, F., Breese, R., Ross, D., Zhang, X. D., Stone, D. J., Ferrer, M., Townsend, M., Wolfe, A. L., Seager, M. A., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.057182 · Cited by 188
Synapse-Associated Protein-97 Mediates α-Secretase ADAM10 Trafficking and Promotes Its Activity
Marcello, E., Gardoni, F., Mauceri, D., Romorini, S., Jeromin, A., Epis, R., Borroni, B., Cattabeni, F., Sala, C., Padovani, A., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3439-06.2007 · Cited by 187
Kirvell, S. L., Esiri, M., & Francis, P. T. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03935.x · Cited by 187
Bussière, T., Giannakopoulos, P., Bouras, C., Perl, D. P., Morrison, J. H., & Hof, P. R. (2003) · Journal of Comparative Neurology · doi:10.1002/cne.10760 · Cited by 185
Memantine Improves Spatial Learning in a Transgenic Mouse Model of Alzheimer’s Disease
Minkeviciene, R., Banerjee, P., & Tanila, H. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.071027 · Cited by 184
Kim, J.-H., Anwyl, R., Suh, Y.-H., Djamgoz, M. B. A., & Rowan, M. J. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-04-01327.2001 · Cited by 182
van Dyck, C. H., Tariot, P. N., Meyers, B., & Malca Resnick, E. (2007) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e318065c495 · Cited by 181
PP2A Regulates Tau Phosphorylation Directly and also Indirectly via Activating GSK-3β
Qian, W., Shi, J., Yin, X., Iqbal, K., Grundke-Iqbal, I., Gong, C.-X., & Liu, F. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1317 · Cited by 180
Hoey, S. E., Williams, R. J., & Perkinton, M. S. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.6017-08.2009 · Cited by 178
Poncer, J. C., Esteban, J. A., & Malinow, R. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-11-04406.2002 · Cited by 177
Gu, Z., Liu, W., & Yan, Z. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806508200 · Cited by 176
Kashani, A., Lepicard, È., Poirel, O., Videau, C., David, J. P., Fallet-Bianco, C., Simon, A., Delacourte, A., Giros, B., Epelbaum, J., et al. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.04.010 · Cited by 175
Caspases, Apoptosis, and Alzheimer Disease: Causation, Correlation, and Confusion
Roth, K. A. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.9.829 · Cited by 175
Vogt, K. E., & Nicoll, R. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.3.1118 · Cited by 174
Genetics of Alzheimer's disease: new evidences for an old hypothesis?
Lambert, J., & Amouyel, P. (2011) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2011.02.002 · Cited by 171
Hölscher, C. (2011) · Biochemical Society Transactions · doi:10.1042/bst0390891 · Cited by 170
Zhao, D., Watson, J. B., & Xie, C.-W. (2004) · Journal of Neurophysiology · doi:10.1152/jn.00485.2004 · Cited by 169
The Role of Tau Phosphorylation in the Pathogenesis of Alzheimers Disease
Mi, K., & Johnson, G. (2006) · Current Alzheimer Research · doi:10.2174/156720506779025279 · Cited by 167
Mitoenergetic failure in Alzheimer disease
Parihar, M. S., & Brewer, G. J. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00232.2006 · Cited by 166
Amyloid peptide attenuates the proteasome activity in neuronal cells
Oh, S., Hong, H. S., Hwang, E., Sim, H. J., Lee, W., Shin, S. J., & Mook-Jung, I. (2005) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2005.07.006 · Cited by 166
Paradoxical Upregulation of Glutamatergic Presynaptic Boutons during Mild Cognitive Impairment
Bell, K. F. S., Bennett, D. A., & Cuello, A. C. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.3269-07.2007 · Cited by 164
Rammes, G., Hasenjäger, A., Sroka-Saidi, K., Deussing, J. M., & Parsons, C. G. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.01.051 · Cited by 163
How do heart disease and stroke become risk factors for Alzheimer's disease?
de la Torre, J. C. (2006) · Neurological Research · doi:10.1179/016164106x130362 · Cited by 161
Wenk, G. L., Parsons, C. G., & Danysz, W. (2006) · Behavioural Pharmacology · doi:10.1097/00008877-200609000-00007 · Cited by 154
Song, M.-S., Rauw, G. A., Baker, G. B., & Kar, S. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06498.x · Cited by 151
Self-citationSze, C., Bi, H., Kleinschmidt-DeMasters, B. K., Filley, C. M., & Martin, L. J. (2001) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(00)00467-6 · Cited by 149
Abnormal Glutamate Transport Function in Mutant Amyloid Precursor Protein Transgenic Mice
Masliah, E., Alford, M. F., Mallory, M. E., Rockenstein, E. M., Moechars, D., & LEUVEN, F. V. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7386 · Cited by 148
Amyloid-β fibrillogenesis: Structural insight and therapeutic intervention
Silva, K. D., Shaw, J. E., & McLaurin, J. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.08.032 · Cited by 146
?-amyloid binds to p75NTRand activates NF?B in human neuroblastoma cells
Kuner, P., Schubenel, R., & Hertel, C. (1998) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19981215)54:6<798::aid-jnr7>3.0.co;2-t · Cited by 145
Glutamate release from microglia via glutamate transporter is enhanced by amyloid-beta peptide
Noda, M., Nakanishi, H., & Akaike, N. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00036-6 · Cited by 144
Pei, J.-J., Gong, C., An, W., Winblad, B. G., Cowburn, R. F., Grundke, I., & Iqbal, K. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63445-1 · Cited by 143
Ting, J. T., Kelley, B. G., Lambert, T. J., Cook, D. G., & Sullivan, J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608807104 · Cited by 140
Bakchine, S., & Loft, H. (2007) · Journal of Alzheimer s Disease · doi:10.3233/jad-2007-11409 · Cited by 140
Neurofibrillary tangles and tau phosphorylation
Brion, J., Anderton, B. H., Authelet, M., Dayanandan, R., Leroy, K., Lovestone, S., Octave, J., Pradier, L., Touchet, N., & Tremp, G. L. (2001) · Biochemical Society Symposia · doi:10.1042/bss0670081 · Cited by 139
Dephosphorylation of Tau by Protein Phosphatase 5
Liu, F., Iqbal, K., Grundke, I., Rossie, S. S., & Gong, C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m410775200 · Cited by 139
Cholinergic activity and amyloid precursor protein metabolism
Roberson, M. R., & Harrell, L. E. (1997) · Brain Research Reviews · doi:10.1016/s0165-0173(97)00016-7 · Cited by 137
Altered synaptic function in Alzheimer's disease
Bell, K. F. S., & Cuello, A. C. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.06.045 · Cited by 135
Rao, V. L. R., Dog⫧an, A., Todd, K. G., Bowen, K. K., & Dempsey, R. J. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02617-8 · Cited by 135
Kar, S., Seto, D., Gaudreau, P., & Quirion, R. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-03-01034.1996 · Cited by 134
Self-citationImplication of calpain in neuronal apoptosis
Raynaud, F., & Marcilhac, A. (2006) · FEBS Journal · doi:10.1111/j.1742-4658.2006.05352.x · Cited by 133
Widespread Changes in Dendritic Spines in a Model of Alzheimer's Disease
Knafo, S., Alonso-Nanclares, L., Gonzalez-Soriano, J., Merino-Serrais, P., Fernaud-Espinosa, I., Ferrer, I., & DeFelipe, J. (2009) · Cerebral Cortex · doi:10.1093/cercor/bhn111 · Cited by 132
Metabotropic glutamate receptors: intracellular signaling pathways
Gerber, U. R., Gee, C. E., & Benquet, P. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.08.008 · Cited by 132
Alvarez, G., Muñoz-Montaño, J. R., Satrústegui, J., Ávila, J., Bogónez, E., & Díaz‐Nido, J. (2002) · Bipolar Disorders · doi:10.1034/j.1399-5618.2002.01150.x · Cited by 131
The amyloid‐β peptide and its role in Alzheimer's disease
Clippingdale, A. B., Wade, J. D., & Barrow, C. J. (2001) · Journal of Peptide Science · doi:10.1002/psc.324 · Cited by 127
Schools, G. P., & Kimelberg, H. K. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19991115)58:4<533::aid-jnr6>3.0.co;2-g · Cited by 127
Scott, H. L., Pow, D. V., Tannenberg, A. E. G., & Dodd, P. R. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-03-j0004.2002 · Cited by 127
Memantine lowers amyloid‐β peptide levels in neuronal cultures and in APP/PS1 transgenic mice
Alley, G. M., Bailey, J. A., Chen, D., Ray, B., Puli, L., Tanila, H., Banerjee, P., & Lahiri, D. K. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22172 · Cited by 126
Alzheimer's disease genetics: current knowledge and future challenges
Hollingworth, P., Harold, D. H., Jones, L., Owen, M. J., & Williams, J. H. (2010) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2628 · Cited by 124
Bennecib, M., Gong, C., Grundke, I., & Iqbal, K. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02127-5 · Cited by 119
Dewar, D., Chalmers, D. T., Graham, D. I., & McCulloch, J. (1991) · Brain Research · doi:10.1016/0006-8993(91)90230-s · Cited by 118
Williams, C., Mehrian Shai, R., Wu, Y., Hsu, Y.-H., Sitzer, T., Spann, B., McCleary, C., Mo, Y., & Miller, C. A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004936 · Cited by 116
Differential expression of N ‐methyl‐ d ‐aspartate receptor NR2 isoforms in Alzheimer's disease
Hynd, M. R., Scott, H. L., & Dodd, P. R. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02548.x · Cited by 116
Albasanz, J. L., Dalfó, E., Ferrer, I., & Martín, M. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.05.001 · Cited by 114
Ułas, J., Weihmuller, F., Brunner, L., Joyce, J. N., Marshall, J., & Cotman, C. W. (1994) · Journal of Neuroscience · doi:10.1523/jneurosci.14-11-06317.1994 · Cited by 114
Changes in the cellular distribution of glutamine synthetase in Alzheimer's disease
Robinson, S. R. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.10057 · Cited by 113
Bakchine, S., & Loft, H. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-13110 · Cited by 111
Surface clustering of metabotropic glutamate receptor 1 induced by long Homer proteins
Kammermeier, P. J. (2006) · BMC Neuroscience · doi:10.1186/1471-2202-7-1 · Cited by 108
Braithwaite, S. P., Adkisson, M., Leung, J., Nava, A., Masterson, B., Urfer, R., Oksenberg, D., & Nikolich, K. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04837.x · Cited by 108
Hernandez, P., Lee, G., Sjoberg, M., & Maccioni, R. B. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-0933 · Cited by 107
Arias, C., Arrieta, I., & Tapia, R. (1995) · Journal of Neuroscience Research · doi:10.1002/jnr.490410416 · Cited by 103
Roselli, F., Hutzler, P., Wegerich, Y., Livrea, P., & Almeida, O. F. X. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006011 · Cited by 97
Sokolow, S., Luu, S. H., Nandy, K., Miller, C. A., Vinters, H. V., Poon, W. W., & Gylys, K. H. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.08.027 · Cited by 97
Fernández-Tomé, P., Brera, B., Arévalo, M., & CEBALLOS, M. L. D. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.12.006 · Cited by 94
Kim, S. H., Fraser, P. E., Westaway, D. A., George‐Hyslop, P. S., Ehrlich, M. E., & Gandy, S. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.4717-09.2010 · Cited by 93
Tang, B. L. (2009) · Cell Adhesion & Migration · doi:10.4161/cam.3.1.7254 · Cited by 92
Tremblay, R. G., Chakravarthy, B., Hewitt, K. E., Tauskela, J. S., Morley, P., Atkinson, T. G., & Durkin, J. P. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-19-07183.2000 · Cited by 87
NMDA receptor antagonists. A new therapeutic approach for Alzheimer's disease.
Farlow, M. R. (2004) · PubMed · Cited by 86
Modulation of the phosphorylation state of tau in situ: the roles of calcium and cyclic AMP
Fleming, L. M., & Johnson, G. V. W. (1995) · Biochemical Journal · doi:10.1042/bj3090041 · Cited by 84
Memantine in dementia: a review of the current evidence
Herrmann, N., Li, A., & Lanctôt, K. L. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2011.558006 · Cited by 84
Rodriguez-Kern, A., Gegelashvili, M., Schousboe, A., Zhang, J., Sung, L., & Gegelashvili, G. (2003) · Neurochemistry International · doi:10.1016/s0197-0186(03)00023-8 · Cited by 80
Kowall, N. W., & Beal, M. F. (1991) · Annals of Neurology · doi:10.1002/ana.410290208 · Cited by 80
Cognitive evaluation of disease-modifying efficacy of Galantamine and Memantine in the APP23 model
Dam, D. V., & Deyn, P. P. D. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.06.005 · Cited by 78
LeBlanc, A. C., Chen, H. Y., AUTILIO‐GAMBETTI, L., & Gambetti, P. L. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)80861-v · Cited by 76
Gong, Y., & Lippa, C. F. (2010) · American Journal of Alzheimer's Disease & Other Dementias® · doi:10.1177/1533317510382893 · Cited by 76
Pahnke, J., Walker, L. C., Scheffler, K., & Krohn, M. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.05.006 · Cited by 75
Dysregulation of tau phosphorylation in mouse brain during excitotoxic damage.
Liang, Z., Liu, F., Iqbal, K., Grundke-Iqbal, I., & Gong, C.-X. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1069 · Cited by 73
Dong, H., Yuede, C. M., Coughlan, C. A., Lewis, B. L., & Csernansky, J. G. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.53 · Cited by 73
Lee, H., Ogawa, O., Zhu, X., O’Neill, M. J., Petersen, R. B., Castellani, R. J., Ghanbari, H., Perry, G. L., & Smith, M. A. (2004) · Acta Neuropathologica · doi:10.1007/s00401-004-0820-8 · Cited by 72
Moechars, D., Lorent, K., & Leuven, F. V. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00599-5 · Cited by 71
Yasuda, R. P., Ikonomovic, M. D., Sheffield, R., Rubin, R. T., Wolfe, B. B., & Armstrong, D. M. (1995) · Brain Research · doi:10.1016/0006-8993(95)00178-s · Cited by 71
Protection against Aβ-mediated rapid disruption of synaptic plasticity and memory by memantine
Klyubin, I., Wang, Q., Reed, M. N., Irving, E. A., Upton, N., Hofmeister, J., Cleary, J. P., Anwyl, R., & Rowan, M. J. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.04.005 · Cited by 69
Liu, M. C., Kobeissy, F. H., Zheng, W., Zhang, Z., Hayes, R. L., & Wang, K. (2010) · ASN NEURO · doi:10.1042/an20100012 · Cited by 66
Orthostatic hypotension. A primary care primer for assessment and treatment.
Sclater, A. L., & Alagiakrishnan, K. (2004) · PubMed · Cited by 63
Jhamandas, J. H., & MacTavish, D. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.1051-04.2004 · Cited by 62
Self-citationGlobal prevalence of dementia: a Delphi consensus study
(2006) · Tijdschrift voor VerpleeghuisGeneeskunde · doi:10.1007/bf03075138 · Cited by 60
β-Amyloid-related peptides potentiate K+-evoked glutamate release from adult rat hippocampal slices
Kabogo, D., Rauw, G. A., Amritraj, A., Baker, G. B., & Kar, S. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.08.009 · Cited by 58
Self-citationAronica, E., Dickson, D. W., Kress, Y., Morrison, J. H., & Zukin, R. S. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00260-1 · Cited by 58
Ikonomović, M. D., Mizukami, K., Warde, D., Sheffield, R., Hamilton, R. L., Wenthold, R. J., & Armstrong, D. M. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7196 · Cited by 57
Shashidharan, P., Huntley, G. W., Meyer, T., Morrison, J. H., & Plaitakis, A. (1994) · Brain Research · doi:10.1016/0006-8993(94)90819-2 · Cited by 57
Chin, J. H., Ma, L., MacTavish, D., & Jhamandas, J. H. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.1843-07.2007 · Cited by 56
Self-citation
Cited by
Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease
Stockwell, B. R., Friedmann Angeli, J. P., Bayir, H., Bush, A. I., Conrad, M., Dixon, S. J., Fulda, S., Gascón, S., Hatzios, S. K., Kagan, V. E., et al. (2017) · Cell · doi:10.1016/j.cell.2017.09.021 · Cited by 7,695
Therapeutics of Alzheimer's disease: Past, present and future
Anand, R., Gill, K. D., & Mahdi, A. A. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.07.004 · Cited by 747
Rajmohan, R., & Reddy, P. H. (2017) · Journal of Alzheimer’s Disease · doi:10.3233/jad-160612 · Cited by 688
Neuroprotective Effects of Quercetin in Alzheimer’s Disease
Khan, H., Ullah, H., Aschner, M., Cheang, W. S., & Akkol, E. K. (2019) · Biomolecules · doi:10.3390/biom10010059 · Cited by 537
Alzheimer’s disease and its treatment by different approaches: A review
Srivastava, S., Ahmad, R., & Khare, S. K. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113320 · Cited by 467
Metadata
- Authors
- Revett, T. J., Baker, G. B., Jhamandas, J., & Kar, S.
- Venue
- Journal of Psychiatry and Neuroscience
- Publisher
- Canadian Science Publishing
- Published
- 2013-01
- Volume
- 38
- Issue
- 1
- Pages
- 6-23
- ISSN
- 1180-4882 (ISSN-L)
- 1488-2434
- OpenAlex
- W2140432027
- Cited by
- 292
- References
- 227
- FWCI
- 13.21
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.